Drugs / DTRI-031
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05005520 Comparator | Oct 2021 → Apr 2022 | — | Basking Biosciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTRI-031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05005520 ↗ |
| Route | Intravenous | “via intravenous injection” NCT05005520 ↗ |